Pharmaceutical Industry Information Portal

HomeNews

News

NANOLEK will invest 5 billion rubles in the full production cycle

Nanolek, a biopharmaceutical company, announces a plan to invest 5 billion rubles over 3 years in its full-cycle vaccine production facility in the Kirov region and an R&D Center for Biotech Medicines in Moscow.

TriRx Enters Agreement for the Acquisition of Elanco Animal Health Facilities

TriRx Pharmaceutical Services Inc., a leading international CDMO, today announced an agreement to acquire two facilities from Elanco Animal Health Incorporated. Elanco is a...

EU Approval of Russia’s Sputnik V Vaccine Delayed – Reuters

European Union approval of Russia’s Sputnik V coronavirus vaccine will be delayed because a June 10 deadline to submit data was missed, two people...

Yposkesi launches construction of its second commercial bioproduction site

Yposkesi, a leading Contract Development and Manufacturing Organization (CDMO) specializing in cell and gene therapies, announces the launch of project SKY, the construction of...

Novavax Covid-19 Vaccine demonstrates 90,4% Effective in Late-stage Trial

Biotech company Novavax said that its COVID-19 vaccine is 90.4% effective in a late-stage trial of nearly 30,000 people in the U.S. and Mexico

Global Biopharmaceutical Industry is on track to produce at least 10 billion doses of COVID-19 vaccine by end 2021

Biopharmaceutical industry welcomes COVID-19 vaccine-sharing pledges but warn challenges remain to urgently address vaccine inequity
spot_img

Expert Articles

spot_img